Madrigal Pharmaceuticals income from continuous operations for the twelve months ending December 31, 2024 was $-0.466B, a 24.69% increase year-over-year.
Madrigal Pharmaceuticals annual income from continuous operations for 2024 was $-0.466B, a 24.69% increase from 2023.
Madrigal Pharmaceuticals annual income from continuous operations for 2023 was $-0.374B, a 26.5% increase from 2022.
Madrigal Pharmaceuticals annual income from continuous operations for 2022 was $-0.295B, a 22.12% increase from 2021.